Catalysis Blue Cap Products Adulterated Due To Undeclared Corticosteroids
This article was originally published in The Tan Sheet
Blue Cap spray, cream and shampoo with zinc pyrithione may not carry an indication for psoriasis, FDA's Florida District Office informs Miami-based Catalysis in a July 11 warning letter.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC